Latest News
Asana Stock Tumbles 13% as AI Costs Bite Into Margins
Asana shares plunged 13% despite an earnings beat, as the company's AI push adds 150 basis points of margin pressure. Revenue guidance was in line, but AI costs weighed on the stock.
GoPro Surges 24% as Market Decodes Merger Value
GoPro shares jumped 24% as deal math suggests a $5.80 value for the merged company, though investors lack key financials.
AMC Stock Jumps 5% as CEO Escalates Fight Over Robinhood Crypto Tokens
AMC shares jumped 5% after CEO Adam Aron demanded Robinhood halt AMC-linked stock tokens, raising questions about capital raising and investor demand.
Sandisk Stock Soars 10.5% as NAND Pricing Momentum Builds
Sandisk shares surged 10.5% after strong Q4 results and robust NAND pricing. The company's 84.6% gross margin raises questions about sustainability.
Astera Labs Soars 11% as Scorpio Ramp Tests Investor Confidence
Astera Labs (ALAB) surged 11% to $313.84, but Q3 guidance requires 40% sequential revenue growth. Scorpio ramp and customer concentration are key risks.
Cerebras Surges 12% as Finland Deal Bolsters $51B Valuation
Cerebras Systems shares jumped 12% to $213.26, lifting market value to $50.7B. A Finnish data center contract underpins the high valuation, with delivery and margins key.
Nvidia's $12.93B Hugging Face Deal: Market's Muted Response Explained
Nvidia's $12.93B acquisition of Hugging Face barely moved its stock, up 1.37%. The deal's strategic value lies in developer insights, but financials remain undisclosed.
Deepa Jewellers IPO Oversubscribed 42.6x, But Cash Flow Concerns Loom
Deepa Jewellers' IPO was oversubscribed 42.6 times, but the company's operating cash flow remained negative despite a 158% profit surge, raising concerns.
Tesla Shares Tumble as Federal Audit Casts Doubt on Cybercab Rollout
Tesla shares dropped 6.5% as NHTSA audits Cybercab self-certification, erasing Thursday's rally. The audit could slow the robotaxi's path to commercial scale.
UiPath Shares Plunge 17% as ARR Growth Target Slows
UiPath (PATH) shares dropped 17% after Q2 results, as the company's full-year ARR guidance implies a significantly faster growth pace in the second half.